$DNDN Headlines Dendreon jumps on winning European

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2013 at 7:02 PM

$DNDN Headlines

Dendreon jumps on winning European approval for prostate-cancer treatment 11:31 a.m. Sept. 17, 2013 - Russ Britt
Storm clouds getting darker for troubled Seattle biotech Dendreon 10:49 a.m. Aug. 23, 2013 - Russ Britt
Dendreon shares slump 16% on poor Provenge outlook 8:12 a.m. Aug. 9, 2013 - MarketWatch
In focus: Bears have another chance 8:09 p.m. Aug. 7, 2013 - Lawrence G. McMillan
As cancer drug sales struggle, Dendreon shares plunge 12:14 p.m. May 9, 2013 - Russ Britt
Analyst apologizes to clients for his call on Dendreon, stock climbs 12:00 p.m. March 7, 2013 - blogs.marketwatch.com
Four charts to watch 2:03 p.m. Feb. 7, 2013 - The Trading Deck
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s movers; Best Buy has best day in 4 years 4:47 p.m. Jan. 11, 2013 - Sue Chang
Bernstein lifts Dendreon price target to $10 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Dendreon upgraded to outperform by Bernstein 7:34 a.m. Jan. 11, 2013 - Greg Morcroft
Analyst downgrades rain on Dendreon 2:43 p.m. July 31, 2012 - Val Brickates Kennedy
Dendreon down 21% on earnings, restructuring news 9:27 a.m. July 31, 2012 - Val Brickates Kennedy
Updates, advisories and surprises 7:31 p.m. July 30, 2012 - MarketWatch
Seagate shares drop on earnings, outlook 5:33 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to slash jobs amid tepid earnings 5:12 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares drop 18% after being unhalted 5:10 p.m. July 30, 2012 - Wallace Witkowski
Dendreon to restructure, slash 600 jobs 3:31 p.m. July 30, 2012 - Val Brickates Kennedy
Dendreon shares halted for news pending 3:13 p.m. July 30, 2012 - Laura Mandaro
Savient to slash workforce by 35% 11:08 a.m. July 9, 2012 - MarketWatch.com

DNDN January 2014 Options Begin Trading 10:53 a.m. Nov. 27, 2013 - TheStreet.com
Dendreon Has Hidden Value For The Right Buyer 2:04 p.m. Nov. 25, 2013 - Seeking Alpha
DNDN December 27th Options Begin Trading 10:56 a.m. Nov. 21, 2013 - TheStreet.com
Dendreon (DNDN) Highlighted As Today's Perilous Reversal Stock 3:33 p.m. Nov. 20, 2013 - TheStreet.com
Dendreon (DNDN) in Focus: Stock Moves 9.7% Higher - Tale of the Tape 8:30 a.m. Nov. 20, 2013 - Zacks.com
Investments On Biotech's Cutting Edge: Joseph Pantginis 4:41 p.m. Nov. 18, 2013 - Seeking Alpha
The Immunotherapy Company You Never Saw Coming: Advaxis CSO Interview 12:48 p.m. Nov. 17, 2013 - Seeking Alpha
Dendreon Narrows Loss, Provenge Disappoints Again - Analyst Blog 9:50 a.m. Nov. 15, 2013 - Zacks.com
Dendreon: A Classic Plan Of Desperation 2:38 p.m. Nov. 13, 2013 - Seeking Alpha
Dendreon's Earnings Review 10:47 a.m. Nov. 13, 2013 - Seeking Alpha
Dendreon Has Another Disaster Quarter 9:02 a.m. Nov. 13, 2013 - Seeking Alpha
Combination Therapies Hold Key To Future Cancer Treatments 2:32 p.m. Nov. 12, 2013 - Seeking Alpha
Dendreon Corporation CEO Discusses Q3 2013 Results - Earnings Call Transcript 11:59 a.m. Nov. 12, 2013 - Seeking Alpha
Dendreon Restructuring Aims to Thwart Weak Provenge Sales 9:35 a.m. Nov. 12, 2013 - 247WallSt.com
Dendreon Earnings Suck, But Still Send DNDN Stock Higher 3:40 a.m. Nov. 12, 2013 - InvestorPlace.com
Earnings Season Is Not Over: D.R. Horton, Dendreon, Dean Foods And Health Management Associates 10:20 a.m. Nov. 11, 2013 - Seeking Alpha
Is Dendreon A Buy Ahead Of Earnings? 12:45 p.m. Nov. 6, 2013 - Seeking Alpha
December 6th Options Now Available For Dendreon (DNDN) 10:46 a.m. Oct. 31, 2013 - TheStreet.com
The Deal: After String of Miscues, Dendreon Likely on Block 12:59 p.m. Oct. 30, 2013 - TheStreet.com
Biotechnology: Finding The Best And Worst Value In The Industry 10:20 a.m. Oct. 30, 2013 - Seeking Alpha

Dendreon Announces Webcast Presentation at Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 26, 2013 - BusinessWire
Settlement Agreement, Presentation of Trial Results, and Stock Price Update - Research Report on Johnson & Johnson, Mettler-Toledo, Galena Biopharma, Dendreon, and Amedisys 8:00 a.m. Nov. 25, 2013 - PR Newswire
NanoString Technologies Names David W. Ghesquiere Senior Vice President, Corporate & Business Development 4:05 p.m. Nov. 20, 2013 - BusinessWire
Marketing Authorizations, Financial Results, Public Offering and Leadership Transitions - Research Report on Regeneron, Dendreon, Dyax, Techne, and ICU Medical 8:04 a.m. Nov. 15, 2013 - PR Newswire
StemCells, Inc. Appoints Greg Schiffman as Chief Financial Officer 9:00 a.m. Nov. 14, 2013 - GlobeNewswire
Under AAAResearchReports.com Microscope: Repros Therapeutics Inc., Dendreon Corp., Novartis AG, and Stryker Corp. 8:10 a.m. Nov. 13, 2013 - PR Newswire
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Dendreon Announces Third Quarter 2013 Results 8:00 a.m. Nov. 12, 2013 - BusinessWire
RBCC Explores Promising New Breakthroughs in Regenerative Medicine 6:46 a.m. Nov. 5, 2013 - BusinessWire
SNTA, DNDN, ZGNX and NVGN added to NASDAQ Active Stock Watch List at EPR 9:58 a.m. Oct. 28, 2013 - ACCESSWIRE
Market Briefing: Emerging Growth NASDAQ Stocks in the News 3:22 p.m. Oct. 25, 2013 - PR Newswire
Early Briefing and Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 8:00 a.m. Oct. 22, 2013 - PR Newswire
Quarterly Reports, Licensing Agreements, and Clinical Data - Research Report on Theravance, Dendreon, ImmunoGen, Compugen, and Acorda 8:00 a.m. Oct. 22, 2013 - PR Newswire
Mentor Capital Cancer Immunotherapy Index Up 100% in 2013 8:03 a.m. Oct. 16, 2013 - BusinessWire
Dendreon to Host Conference Call on November 12 to Announce Third Quarter Financial Results 4:30 p.m. Oct. 7, 2013 - BusinessWire
Dendreon Corporation Announces Presentation of PROVENGE(R) (sipuleucel-T) Data at the 2013 European Cancer Congress 7:30 a.m. Sept. 27, 2013 - BusinessWire
Pre-Market Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. 8:49 a.m. Sept. 25, 2013 - PR Newswire
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union 8:30 a.m. Sept. 17, 2013 - BusinessWire
MOLX, MNKD, ISIS and DNDN added to Healthcare Stock Watch List at EPR 9:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

GBI Bio's New CEO Jesse McCool to Propel Growth

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Cannabis Industry Pushes for Robust Financial Services

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Cove Capital Secures $9.96M for Debt-Free Logistics DST

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Atli Launches: AI-Powered eSIM Revolutionizes Travel

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

AI Trust in Finance: Survey Reveals Market Impact

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Sacrifice Unending: 9/11's Lingering Health Toll

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...